Nicholas W Hubbard

5PUBLICATIONS
35CO-AUTHORS
Predictive and prognostic markersMedical devicesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jan 05, 2024
LITAF protects against pore-forming protein-induced cell death by promoting membrane repair.

Caroline Stefani, Anna M Bruchez, Mario G Rosasco

|Jul 21, 2022
ADAR1 mutation causes ZBP1-dependent immunopathology.

Nicholas W Hubbard, Joshua M Ames, Megan Maurano

|Oct 19, 2021
Cutting Edge: DOCK8 Regulates a Subset of Dendritic Cells That Is Critical for the Development of Experimental Autoimmune Encephalomyelitis.

Asanga Weliwitigoda, Pushpalatha Palle, Melissa Gessner

|Jun 05, 2020
Gene editing to induce FOXP3 expression in human CD4+ T cells leads to a stable regulatory phenotype and function.

Yuchi Honaker, Nicholas Hubbard, Yufei Xiang

|Jun 23, 2019
Intratumoral activation of the necroptotic pathway components RIPK1 and RIPK3 potentiates antitumor immunity.

Annelise G Snyder, Nicholas W Hubbard, Michelle N Messmer

Pageof 1

Frequent Collaborators

3 joint publications

Andrew Oberst

2 joint publications

Karen Sommer

1 joint publications

Yuchi Honaker

1 joint publications

Yufei Xiang